000 01718 a2200493 4500
005 20250514221846.0
264 0 _c20050715
008 200507s 0 0 eng d
022 _a0955-8810
024 7 _a10.1097/00008877-200503000-00002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _ade Oliveira, R V
245 0 0 _aEffect of subchronic caffeine treatment on MK-801-induced changes in locomotion, cognition and ataxia in mice.
_h[electronic resource]
260 _bBehavioural pharmacology
_cMar 2005
300 _a79-84 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdenosine
_xpharmacology
650 0 4 _aAmphetamine
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aAtaxia
650 0 4 _aCaffeine
_xpharmacology
650 0 4 _aCentral Nervous System Stimulants
_xpharmacology
650 0 4 _aCognition
_xdrug effects
650 0 4 _aDisease Models, Animal
650 0 4 _aDizocilpine Maleate
_xpharmacology
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Interactions
650 0 4 _aExcitatory Amino Acid Antagonists
_xpharmacology
650 0 4 _aHumans
650 0 4 _aLocomotion
_xdrug effects
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aReceptors, N-Methyl-D-Aspartate
_xphysiology
650 0 4 _aSchizophrenia
_xphysiopathology
700 1 _aDall'Igna, O P
700 1 _aTort, A B L
700 1 _aSchuh, J F
700 1 _aNeto, P F
700 1 _aSantos Gomes, M W
700 1 _aSouza, D O
700 1 _aLara, D R
773 0 _tBehavioural pharmacology
_gvol. 16
_gno. 2
_gp. 79-84
856 4 0 _uhttps://doi.org/10.1097/00008877-200503000-00002
_zAvailable from publisher's website
999 _c15440545
_d15440545